Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-001538

Director sold 4,000 shares at $76.09 ($304,360)

  • Director acquired 9,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PERRY MICHAEL S · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-01 Grant or award : show line 1 in the form +9,000 94,000 D
2021-01-04 Sale : show line 2 in the form −4,000 $76.09 $304,360 90,000 D
Open-market sales · 4,000 sh · avg $76.09 · $304,360
Loading xslF345X03/doc4.xml…